NCT00676884View on ClinicalTrials.gov

A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema

PHASE2CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

August 31, 2006

Conditions

Atopic Eczema

Interventions

DRUG

Aeroderm (also known as pitrakinra, AER 001, BAY 16-9996)

30 mgs s.c. b.i.d.

DRUG

placebo

1.5 mL s.c. b.i.d.

Trial Locations (1)

SE1 1YR

Guy's Drug Research unit, Quintiles Limited, London

Sponsors

Lead Sponsor

Aerovance, Inc.

All Listed Sponsors

lead

Aerovance, Inc.

INDUSTRY

NCT00676884 - A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema | Biotech Hunter | Biotech Hunter